Aurinia Pharmaceuticals (AUPH) Long-Term Investments (2020 - 2024)

Aurinia Pharmaceuticals (AUPH) has 4 years of Long-Term Investments data on file, last reported at $199000.0 in Q2 2024.

• Quarterly Long-Term Investments changed N/A year-over-year to $199000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $199000.0 (changed N/A YoY) and the FY2023 annual result came in at $201000.0, changed N/A from the prior year.
• Long-Term Investments was little changed at $199000.0 in Q2 2024, from $199000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $24.4 million in Q4 2020 to a low of $199000.0 in Q1 2024.
• A 4-year average of $6.2 million and a median of $591000.0 in 2023 frame the typical range for Long-Term Investments.